Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is malignant cylindroma?
Malignant cylindroma (cylindrocarcinoma) is a very rare cancer of the skin's sweat-gland (adnexal) structures. It most often develops on the scalp, head, or neck, typically arising within a pre-existing benign cylindroma — a slow-growing nodule sometimes called a 'turban tumor' when many cluster on the scalp. A warning sign of malignant change is a long-standing benign nodule that suddenly grows quickly, ulcerates, bleeds, or becomes painful. Many cases are linked to an inherited condition called CYLD cutaneous syndrome (also known as Brooke-Spiegler syndrome), caused by mutations in the CYLD gene, in which people develop multiple skin-appendage tumors over time and have a higher risk of one turning malignant. Malignant cylindroma can invade locally and, less commonly, spread to lymph nodes or distant organs, so it is more serious than its benign counterpart. The mainstay of treatment is complete surgical removal with clear margins, often using margin-controlled techniques. Radiation is frequently added after surgery for high-grade tumors, close or positive margins, or nerve invasion, and is used as the primary treatment when surgery is not possible. Because of the inherited link, genetic counseling and long-term skin and family monitoring are important.
The main types
Doctors group malignant cylindroma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Sporadic malignant cylindroma | A single malignant tumor arising on its own, usually within a previously benign cylindroma; treated with complete surgical removal, often with radiation. |
| Syndrome-associated malignant cylindroma (CYLD cutaneous / Brooke-Spiegler syndrome) | Arising in someone who inherits a CYLD gene mutation and develops multiple skin-appendage tumors; requires genetic counseling, family screening, and ongoing monitoring for new or changing lesions. |
Staging, in plain terms
Malignant cylindroma is too rare to have its own formal staging system, so doctors describe it by how deeply and widely it has grown, its grade, whether the surgical margins are clear, and whether it has invaded nerves or reached lymph nodes. Skin-cancer staging frameworks are adapted. The most important questions are whether the tumor can be completely removed and whether it shows aggressive features — such as nerve invasion or nodal spread — that call for radiation or additional treatment.
| No dedicated staging system; skin-cancer TNM frameworks are adapted (extent, grade, margins, nerve/node involvement) | What it generally means |
|---|---|
| Localized (skin and immediate tissue) | Tumor confined to the skin and underlying soft tissue. Treated with complete surgical removal; radiation is added for high-grade tumors, close margins, or nerve invasion. |
| Locally advanced | Tumor that is larger, deeply invasive, or recurrent. Requires more extensive surgery, usually combined with radiation. |
| Regional or distant spread (uncommon) | Spread to lymph nodes or distant organs. Managed with surgery, radiation, and systemic therapy as appropriate, individualized to the patient. |
The standard of care
Malignant Cylindroma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Complete surgical removal (the main treatment)
Removing the tumor with clear margins — often with margin-controlled (Mohs) surgery on the scalp and face — is the cornerstone of treatment.
Adjuvant radiation
Radiation after surgery improves local control for high-grade tumors, close or positive margins, or nerve invasion, and is the primary treatment when surgery is not feasible.
Genetic counseling and screening
Because many cases are linked to inherited CYLD cutaneous syndrome, genetic counseling, testing, and family screening help identify others at risk and guide monitoring.
Long-term skin monitoring
Regular skin examinations watch for local recurrence and, in syndrome patients, for new tumors or signs of malignant change in existing nodules.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and survive, while healthy cells repair themselves more effectively. In malignant cylindroma, radiation is most often given after surgery to lower the chance the cancer returns — especially when the tumor is high-grade, the margins are close or involved, or it has invaded along nerves, in which case the radiation field is shaped to follow those nerve pathways. When a tumor on the scalp or face cannot be fully removed without unacceptable disfigurement, radiation can serve as the primary treatment. Because these cancers sit on the scalp near the skull and brain, the dose is carefully shaped using modern techniques. Radiation is given as short, painless daily sessions and leaves no radioactivity in your body, so you remain safe to be around family and children.
The main ways radiation is delivered for malignant cylindroma:
Surgery
Wide local excision or margin-controlled (Mohs) surgery removes the tumor with a cuff of healthy tissue; reconstruction may be needed on the scalp or face.
External-beam radiation
Focused radiation after surgery treats the tumor bed and, for nerve-invading tumors, the nerve pathways, improving local control while shaping the dose around the skull and brain.
Systemic therapy (selective)
For the uncommon cases that spread, systemic treatment is individualized; research into targeted approaches reflecting CYLD biology is ongoing.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Surgery with selective radiation for adnexal carcinomas: Case series of malignant cylindroma and related skin-appendage cancers support complete surgical removal as the foundation, with radiation added for high-grade tumors, positive margins, and nerve invasion to improve local control.[1]
Cutaneous adnexal carcinoma case series (2018–2024)
CYLD gene and the Brooke-Spiegler spectrum: Genetic studies link many cylindromas and their rare malignant transformation to inherited CYLD mutations, defining CYLD cutaneous syndrome and supporting genetic counseling and family screening.[2]
CYLD cutaneous syndrome genetics literature (2015–2023)
Margin-controlled surgery on the scalp and face: Reports support Mohs and other margin-controlled excision for skin-appendage cancers in cosmetically and anatomically sensitive areas, balancing complete removal with tissue preservation.[3]
Mohs surgery adnexal tumor series (2017–2024)
Common questions
How do I know if a long-standing scalp bump has turned cancerous? Warning signs include a benign nodule that suddenly grows quickly, ulcerates, bleeds, becomes painful, or changes in appearance. Any such change in a long-standing scalp or skin lump should be evaluated, and a biopsy confirms whether malignant transformation has occurred.
Is malignant cylindroma inherited? Often it is linked to an inherited condition — CYLD cutaneous syndrome (Brooke-Spiegler syndrome) — caused by mutations in the CYLD gene, in which people develop multiple skin-appendage tumors and have a higher risk of one becoming malignant. Genetic counseling and family screening are recommended when this is suspected.
Will I need radiation after surgery? Sometimes. Radiation is added when the tumor is high-grade, the margins are close or involved, or the cancer has invaded along nerves — features that raise the chance of return. For a small, completely removed low-grade tumor, surgery alone may be enough. Your team will tailor the plan to your tumor.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.